Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) Research & Development (2016 - 2025)

Glaukos (GKOS) has disclosed Research & Development for 12 consecutive years, with $43.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 19.5% to $43.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $150.6 million, a 10.4% increase, with the full-year FY2025 number at $150.6 million, up 10.4% from a year prior.
  • Research & Development was $43.7 million for Q4 2025 at Glaukos, up from $38.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $43.7 million in Q4 2025 to a low of $21.2 million in Q1 2021.
  • A 5-year average of $32.5 million and a median of $33.3 million in 2023 define the central range for Research & Development.
  • Biggest YoY gain for Research & Development was 42.07% in 2021; the steepest drop was 14.69% in 2021.
  • Glaukos' Research & Development stood at $26.7 million in 2021, then soared by 34.24% to $35.8 million in 2022, then grew by 3.49% to $37.1 million in 2023, then dropped by 1.44% to $36.5 million in 2024, then grew by 19.5% to $43.7 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's Research & Development are $43.7 million (Q4 2025), $38.1 million (Q3 2025), and $36.5 million (Q2 2025).